FLIBANOACT 100 MG 28 TABS

Pharmacology The mechanism of action in the treatment of premenopausal women with hypoactive sexual desire disorder is not known. Flibanserin exhibits agonist activity at 5-HT1A and antagonist activity at 5-HT2A; moderate antagonist activity is seen at the 5-HT2B 5-HT2C and dopamine D4 receptors. Indications Hypoactive sexual desire disorder: Treatment of premenopausal women with acquired generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and not due to a coexisting medical or psychiatric condition problems within the relationship or the effects of a medication or other drug substance. Limitations of use: Flibanserin is not indicated for the treatment of HSDD in postmenopausal women or in men or to enhance sexual performance. Dose: 100 mg once daily at bedtime. assess treatment efficacy at 8 weeks and discontinue if symptoms have not improved.